Concepedia

Lianbo Li

LL

Statistics

Publications

25

Citations

1.5K

H-Index

19

Active since

2010

Affiliations

The University of Texas Southwestern Medical Center(Current)

Dana-Farber Cancer Institute

Harvard University

Shanghai University of Traditional Chinese Medicine

University of Turin

Lianbo Li is an author at The University of Texas Southwestern Medical Center specializing in medicine, molecular biology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryMolecular BiologyEngineeringCell BiologyCell SignalingSignal TransductionBiophysicsImmunology

Publications per year

2010–2023

25

Publications

25

Exploring Targeted Degradation Strategy for Oncogenic KRASG12C

Mei Zeng, Yuan Xiong, Nozhat Safaee et al. · Cell chemical biology · 2019 · 266 citations · Full text

Oncogenic Agent, Molecular Biology, Degradation Reaction +3

Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype

Yanke Liang, Alan L. Leggett, Woojun D. Park et al. · Cell chemical biology · 2019 · 161 citations · Full text

Signal Transduction, Signaling Pathway, Cell Division +8

MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis

Yan Yang, Lili Ding, Qun Hu et al. · Molecular Cancer · 2017 · 148 citations · Full text

Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C

Mei Zeng, Jia Lu, Lianbo Li et al. · Cell chemical biology · 2017 · 134 citations · Full text

Medicinal Chemistry, Kras G12c, Medicine +6

Discovery of a selective inhibitor of doublecortin like kinase 1

Fleur M. Ferguson, Behnam Nabet, Srivatsan Raghavan et al. · Nature Chemical Biology · 2020 · 111 citations · Full text

Medicine, Receptor Tyrosine Kinase, Kinase 1 +5

1–5 of 25